About Kothari Fermentation and Biochem Limited
Data last updated:
Kothari Fermentation and Biochem Limited is a public limited company based in New Delhi, Delhi, India. It operates in the industrial enzymes and biochemicals segment of the chemicals and materials sector. It was incorporated on 26 December 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN L72411DL1990PLC042502. Its GSTIN is 07AABCK7907L1Z8 (Delhi). The company holds 11 GST registrations, of which 10 are active. Its shares are listed on BSE: 507474.
The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹15 Cr. It is led by directors including Pramod Kumar Kothari (Managing Director) and Kavita Devi Kothari (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 16 Community Centrefirst Floor Saket, New Delhi, Delhi, India – 110017.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹112.13 Cr, a decline of 1.8% compared to the previous year. For the same year it recorded a net loss of ₹2.99 Cr (net margin -2.7%) and EBITDA of ₹6.5 Cr (EBITDA margin 5.8%).
The company has about 173 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Kothari Fermentation and Biochem. As per MCA filings, the company has open charges of ₹31.48 Cr and satisfied charges of ₹112.95 Cr on record. Court records list 30 cases involving the company, including 23 filed by the company and 6 filed against it; 12 cases are pending. The company has 14 deals on record (14 market trades); the latest was in March 2025. Its 10 peer companies in the Chemicals industry (Enzymes) are compared by revenue, 5 larger and 5 smaller; the largest is Krishna Enzytech Private Limited with revenue of ₹233.37 Cr. The company has 2 MSME Form 1 returns on record between 2023 and 2024, listing 16 overdue payments to 10 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kothariyeast.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address16 Community Centrefirst Floor Saket, New Delhi, Delhi, India – 110017
- IndustryChemicals and Materials, Industrial Enzymes & Biochemicals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Kothari Fermentation and Biochem Limited
The main business activity of Kothari Fermentation and Biochem is manufacturing. In detail, this covers food, beverages and tobacco products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C1 | Food, beverages and tobacco products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Kothari Fermentation and Biochem Limited FY 2025-26 filings available
Kothari Fermentation and Biochem Limited reported revenue of ₹112.13 Cr (down 1.8% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 112 | 114 | 109 | 110 | 97.03 | 95.55 | 96.74 |
| Revenue growth | -1.8% | +4.9% | -1.3% | +13.7% | +1.6% | -1.2% | - |
| EBITDA | 6.50 | 11.87 | 5.15 | 8.82 | 10.19 | 14.32 | 14.51 |
| EBITDA margin | +5.8% | +10.4% | +4.7% | +8.0% | +10.5% | +15.0% | +15.0% |
| Profit before tax | (3.46) | 1.93 | (3.93) | 0.29 | 1.50 | 5.77 | 10.90 |
| Net profit | (2.99) | 0.80 | (4.92) | 0.19 | 0.30 | 4.80 | 7.69 |
| Net profit margin | -2.7% | +0.7% | -4.5% | +0.2% | +0.3% | +5.0% | +8.0% |
| EPS (₹) | (1.99) | 0.54 | (3.27) | 0.13 | 0.20 | 3.20 | 5.11 |
| Balance sheet | |||||||
| Total assets | - | 105 | 107 | 109 | 109 | 102 | 91.95 |
| Net worth | - | 56.57 | 55.91 | 60.85 | 60.57 | 60.29 | 55.55 |
| Total debt | - | 43.43 | 46.95 | 44.84 | 45.42 | 39.13 | 34.05 |
| Cash & bank | - | 0.50 | 0.46 | 0.35 | 0.74 | 0.71 | 0.55 |
| Net working capital | - | 19.15 | 17.94 | 20.47 | 18.18 | 16.07 | 18.02 |
| Cash flow | |||||||
| Cash from operations | - | 10.70 | 8.63 | 6.05 | 9.52 | 15.08 | 6.97 |
| Cash from investing | - | (3.56) | (7.19) | (2.57) | (12.77) | (16.77) | (15.83) |
| Cash from financing | - | (7.11) | (1.38) | (3.49) | 3.27 | 1.52 | 8.44 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 30.41 | 32.47 | 31.95 | 23.96 | 23.75 | 32.18 | 30.53 | 25.17 |
| Revenue growth (YoY) | +28.0% | +0.9% | +4.7% | -4.8% | -9.9% | - | - | - |
| Other income | 0.04 | 0.73 | 0.01 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 |
| Total expenses | 27.76 | 29.56 | 29.57 | 24.41 | 22.10 | 27.76 | 27.35 | 24.28 |
| EBITDA | 2.65 | 2.91 | 2.38 | (0.45) | 1.65 | 4.42 | 3.18 | 0.89 |
| EBITDA margin | +8.7% | +9.0% | +7.4% | -1.9% | +6.9% | +13.7% | +10.4% | +3.5% |
| Depreciation | 1.74 | 1.75 | 1.75 | 1.75 | 1.75 | 1.61 | 1.61 | 1.61 |
| Interest | 0.91 | 1.09 | 0.91 | 0.90 | 0.80 | 1.03 | 0.85 | 0.83 |
| Profit before tax | 0.04 | 0.80 | (0.27) | (3.10) | (0.90) | 1.81 | 0.72 | (1.55) |
| Tax | (0.03) | (0.47) | 0.11 | (0.02) | 0.24 | 0.76 | 0.31 | 0.19 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 30.41 | 32.47 | 31.95 | 23.96 | 23.75 | 32.18 | 30.53 | 25.17 |
| Revenue growth (YoY) | +28.0% | +0.9% | +4.7% | -4.8% | -9.9% | - | - | - |
| Other income | 0.04 | 0.73 | 0.01 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 |
| Total expenses | 27.76 | 29.56 | 29.57 | 24.41 | 22.10 | 27.76 | 27.35 | 24.28 |
| EBITDA | 2.65 | 2.91 | 2.38 | (0.45) | 1.65 | 4.42 | 3.18 | 0.89 |
| EBITDA margin | +8.7% | +9.0% | +7.4% | -1.9% | +6.9% | +13.7% | +10.4% | +3.5% |
| Depreciation | 1.74 | 1.75 | 1.75 | 1.75 | 1.75 | 1.61 | 1.61 | 1.61 |
| Interest | 0.91 | 1.09 | 0.91 | 0.90 | 0.80 | 1.03 | 0.85 | 0.83 |
| Profit before tax | 0.04 | 0.80 | (0.27) | (3.10) | (0.90) | 1.81 | 0.72 | (1.55) |
| Tax | (0.03) | (0.47) | 0.11 | (0.02) | 0.24 | 0.76 | 0.31 | 0.19 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 112 | 114 | 109 | 110 | 97.03 | 95.55 | 96.74 |
| Revenue growth | -1.8% | +4.9% | -1.3% | +13.7% | +1.6% | -1.2% | - |
| Other income | 0.74 | 0.09 | 0.04 | 0.19 | 0.14 | 0.17 | 3.16 |
| Total expenses | 106 | 102 | 104 | 101 | 86.84 | 81.23 | 82.23 |
| Employee cost | 0.00 | 11.34 | 10.70 | 10.38 | 9.63 | 8.79 | 8.05 |
| EBITDA | 6.50 | 11.87 | 5.15 | 8.82 | 10.19 | 14.32 | 14.51 |
| EBITDA margin | +5.8% | +10.4% | +4.7% | +8.0% | +10.5% | +15.0% | +15.0% |
| Depreciation | 7.00 | 6.44 | 5.62 | 5.81 | 5.81 | 5.16 | 4.43 |
| Interest | 3.70 | 3.59 | 3.50 | 2.91 | 3.02 | 3.56 | 2.34 |
| Profit before tax | (3.46) | 1.93 | (3.93) | 0.29 | 1.50 | 5.77 | 10.90 |
| Tax | (0.47) | 1.13 | 0.99 | 0.10 | 1.20 | 0.97 | 3.22 |
| Net profit | (2.99) | 0.80 | (4.92) | 0.19 | 0.30 | 4.80 | 7.69 |
| Net profit margin | -2.7% | +0.7% | -4.5% | +0.2% | +0.3% | +5.0% | +8.0% |
| EPS (₹) | (1.99) | 0.54 | (3.27) | 0.13 | 0.20 | 3.20 | 5.11 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | - | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 |
| Reserves & surplus | - | 41.57 | 40.91 | 45.85 | 45.57 | 45.29 | 40.55 |
| Shareholders' funds (net worth) | - | 56.57 | 55.91 | 60.85 | 60.57 | 60.29 | 55.55 |
| Secured loans | - | 19.53 | 25.08 | 27.54 | 32.71 | 15.49 | 30.10 |
| Unsecured loans | - | 23.90 | 21.87 | 17.30 | 12.71 | 23.64 | 3.95 |
| Total debt | - | 43.43 | 46.95 | 44.84 | 45.42 | 39.13 | 34.05 |
| Total liabilities | - | 105 | 107 | 109 | 109 | 102 | 91.95 |
| Assets | |||||||
| Gross block | - | 156 | 145 | 126 | 126 | 123 | 110 |
| Net block | - | 91.97 | 87.00 | 73.88 | 79.63 | 82.12 | 74.46 |
| Capital work in progress | - | 0.00 | 7.81 | 19.39 | 16.26 | 6.72 | 2.91 |
| Investments | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | - | 23.55 | 21.03 | 22.47 | 18.20 | 14.49 | 15.49 |
| Sundry debtors | - | 9.47 | 9.06 | 7.81 | 5.66 | 6.17 | 7.56 |
| Cash & bank balances | - | 0.50 | 0.46 | 0.35 | 0.74 | 0.71 | 0.55 |
| Loans & advances | - | 1.47 | 5.99 | 6.18 | 7.44 | 4.23 | 3.65 |
| Total current assets | - | 34.99 | 36.54 | 36.81 | 32.04 | 25.60 | 27.25 |
| Total current liabilities | - | 15.84 | 18.60 | 16.34 | 13.86 | 9.53 | 9.23 |
| Net working capital | - | 19.15 | 17.94 | 20.47 | 18.18 | 16.07 | 18.02 |
| Total assets | - | 105 | 107 | 109 | 109 | 102 | 91.95 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | - | 0.21 | 0.15 | 0.18 | 0.16 | 0.33 | 0.74 |
| Net cash from operating activities | - | 10.70 | 8.63 | 6.05 | 9.52 | 15.08 | 6.97 |
| Net cash from investing activities | - | (3.56) | (7.19) | (2.57) | (12.77) | (16.77) | (15.83) |
| Net cash from financing activities | - | (7.11) | (1.38) | (3.49) | 3.27 | 1.52 | 8.44 |
| Net change in cash | - | 0.03 | 0.06 | (0.02) | 0.01 | (0.16) | (0.42) |
| Closing cash | - | 0.50 | 0.46 | 0.35 | 0.74 | 0.71 | 0.55 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -1.8% | +4.9% | -1.3% | +13.7% | +1.6% | -1.2% | - |
| EBITDA growth | -45.2% | +130.5% | -41.6% | -13.4% | -28.8% | -1.3% | - |
| PBT growth | - | +9998.0% | - | -80.7% | -74.0% | -47.1% | -12.7% |
| Net income growth | -473.8% | +116.3% | -2689.5% | -36.7% | -93.8% | -37.6% | - |
| Revenue CAGR (3Y) | +0.6% | +5.6% | +4.5% | +4.5% | +0.3% | +2.9% | +7.0% |
| EBITDA CAGR (3Y) | -9.7% | +5.2% | -28.9% | -15.3% | -16.9% | +6.4% | +18.2% |
| Profitability & leverage | |||||||
| Net income margin | -2.7% | +0.7% | -4.5% | +0.2% | +0.3% | +5.0% | +7.9% |
| Return on capital employed | - | +5.2% | -0.4% | +2.9% | +4.3% | +9.6% | +16.0% |
| Return on net worth | - | +1.4% | -8.4% | +0.3% | +0.5% | +8.3% | +14.8% |
| Debt / equity | - | 0.80 | 0.79 | 0.74 | 0.70 | 0.63 | 0.55 |
| Long-term debt / equity | - | 0.49 | 0.49 | 0.46 | 0.43 | 0.38 | 0.35 |
| Interest cover | -740.00 | 66.11 | -744.68 | 96.68 | 68.95 | 38.86 | 23.21 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 0.76 | 0.81 | 0.88 | 0.78 | 0.82 | 1.01 |
| Inventory turnover | - | 5.12 | 5.01 | 5.42 | 5.94 | 6.37 | 8.20 |
| Debtors turnover | - | 12.33 | 12.91 | 16.37 | 16.40 | 13.92 | 13.39 |
| EPS (₹) | (1.99) | 0.54 | (3.27) | 0.13 | 0.20 | 3.20 | 5.11 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 37.71 | 37.27 | 40.56 | 40.38 | 40.19 | 37.03 |
Peer Comparison of Kothari Fermentation and Biochem Limited
Kothari Fermentation and Biochem Limited is compared with the companies closest to it by revenue in the Chemicals industry (Enzymes). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Krishna Enzytech Private Limited | ₹233.37 Cr (FY 2025) | •••• | •••• | 83.0% | •••• | Thane, Maharashtra, India |
| Sanzyme Biologics Private Limited | ₹226.14 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Hyderabad, Telangana, India |
| Shri Tradco India Private Limited | ₹222.72 Cr (FY 2020) | •••• | •••• | -83.0% | •••• | Mumbai, Maharashtra, India |
| Catalysts Bio-Technologies Private Limited | ₹164.58 Cr (FY 2024) | •••• | •••• | 5.0% | •••• | Delhi, India |
| Meteoric Biopharmaceuticals Private Limited | ₹126 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Ahmedabad, Gujarat, India |
| Kothari Fermentation and Biochem Limited this company | ₹112.13 Cr (FY 2026) | •••• | •••• | -1.8% | •••• | New Delhi, Delhi, India |
| Anthem Cellutions ( India) Private Limited | ₹91.31 Cr (FY 2017) | •••• | •••• | -11.0% | •••• | Bangalore, Karnataka, India |
| Advenza Global Limited | ₹62.48 Cr (FY 2025) | •••• | •••• | -57.0% | •••• | Thane, Maharashtra, India |
| Amylo Dex Private Limited | ₹60.75 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Hyderabad, Telangana, India |
| Zytex Biotech Private Limited | ₹59.95 Cr (FY 2024) | •••• | •••• | 24.0% | •••• | Mumbai, Maharashtra, India |
| Lumis Biotech Private Limited | ₹57.84 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Kothari Fermentation and Biochem by revenue in the Chemicals industry (Enzymes), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Kothari Fermentation and Biochem Limited
Kothari Fermentation and Biochem Limited is audited by Kothari Kuldeep & Co. for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Kothari Kuldeep & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Kothari Fermentation and Biochem Limited
Kothari Fermentation and Biochem has 6 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pramod Kumar Kothari | Managing Director | 26 Dec 1990 | 35 Years 9 Months | Current |
| Kavita Devi Kothari | Whole-Time Director | 01 Apr 2013 | 13 Years 6 Months | Current |
| Piyush Kumar Goel | Director | 27 Sep 2019 | 7 Years 0 Months | Current |
| Hemendra Patsingh Dugar | Director | 14 Nov 2018 | 7 Years 10 Months | Current |
| Siddhant Kothari Also directs: Graff Minerals Private Limited, KGS Global Ventures LLP | Whole-Time Director | 29 Aug 2020 | 6 Years 1 Months | Current |
| Varun Kumar | Director | 13 Aug 2025 | 1 Years 1 Months | Current |
Shareholding Pattern of Kothari Fermentation and Biochem Limited
Shareholding for the quarter ended Mar 2026: promoters hold 68.90%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 31.10%.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | |
|---|---|---|---|---|
| Promoters | 68.90% | 68.90% | 68.90% | 70.10% |
| Public | 31.10% | 31.10% | 31.10% | 29.90% |
Charges & Borrowings of Kothari Fermentation and Biochem Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jun 2026 | Others | ₹50 Lakh | Open |
| 21 May 2026 | Others | ₹25.2 Lakh | Open |
| 24 Mar 2026 | Others | ₹17 Lakh | Open |
| 22 Dec 2025 | Others | ₹28.5 Cr | Open |
| 17 May 2023 | Others | ₹22.05 Lakh | Open |
Total charge records: 28 View all charges
Deals & Funding of Kothari Fermentation and Biochem Limited
Kothari Fermentation and Biochem Limited has 14 deals on record (14 market trades); the latest was in March 2025.
Deals on record (5 of 14)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2022 | Market trade | ₹43.1 Lakh | Seller: Glocom Impex Private Limited |
| Feb 2012 | Market trade | ₹11.7 Lakh | Buyer: an individual Seller: Rashi Fincorp Limited |
| Jul 2007 | Market trade | ₹4.7 Lakh | Seller: Indian Syntans Investments Private Limited |
| Jul 2007 | Market trade | ₹4.4 Lakh | Seller: Indian Syntans Investments Private Limited |
| Jul 2007 | Market trade | ₹4.8 Lakh | Seller: Indian Syntans Investments Private Limited |
Full deal history
All 14 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Kothari Fermentation and Biochem Limited
Kothari Fermentation and Biochem Limited has 30 court cases on record: 23 filed by Kothari Fermentation and Biochem, 6 filed against it, 1 where it is another party. 12 cases are pending and 18 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 19 | 0 | 4 |
| District courts | 11 | 6 | 8 |
Cases on record (5 of 30)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed against the company by Siemens Financial Services Private Limited | Pending |
| District court, New Delhi, Delhi | Criminal case | Filed against the company by Siemens Financial Services Private Limited | Pending |
| High Court of Delhi | Appeal | Filed by the company against Indra Baked Products Private Limited | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed against the company by Siemens Fiancial Services Pvt Ltd | Pending |
| District court, Sangareddy, Telangana | Court case (S.O.P) | Company is another party | Pending |
Full case history
All 30 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Kothari Fermentation and Biochem Limited
Kothari Fermentation and Biochem Limited has 2 MSME Form 1 returns on record between 2023 and 2024, listing 16 overdue payments to 10 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 10)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Asan Engineers Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Meerut Packaging Industries | •••• | •••• | •••• |
| Spack Coaters Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Kothari Fermentation and Biochem Limited
Kothari Fermentation and Biochem operates one associated brand: Kothari Fermentation and Biochem. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Plant-based yeast is manufactured and exported by the company. | kothariyeast.in |
Employees and EPFO Compliance at Kothari Fermentation and Biochem Limited
Kothari Fermentation and Biochem Limited has a workforce of 173 employees as of Apr 04, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
News related to Kothari Fermentation and Biochem Limited
Recent Activity on Kothari Fermentation and Biochem Limited
Kothari Fermentation and Biochem Limited has 27 board changes on record since 1990: 17 appointments and 10 cessations. The latest: Rajiv Agarwal ceased to be Director on 13 Aug 2025.
67 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Kothari Fermentation and Biochem Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kothari Fermentation and Biochem Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Kothari Fermentation and Biochem Limited
Kothari Fermentation and Biochem has 11 GST registrations: 10 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCK7907L1Z8 | Delhi | Active | 01 Jul 2017 |
| 07AABCK7907L2Z7 | Delhi | Active | 16 Jul 2017 |
| 03AABCK7907L1ZG | Punjab | Active | 01 Jul 2017 |
| 08AABCK7907L1Z6 | Rajasthan | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kothari Fermentation and Biochem Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kothari Fermentation and Biochem Limited
Kothari Fermentation and Biochem is an active public limited company based in New Delhi, Delhi, India. The company works in industrial enzymes and biochemicals, within the chemicals and materials industry. It was incorporated on 26 December 1990 (36+ years old) and is registered under CIN L72411DL1990PLC042502. Listed on BSE: 507474.
Kothari Fermentation and Biochem reported revenue of ₹112.13 Cr for FY 2025-26 (down 1.8% YoY) based on standalone financials.
Kothari Fermentation and Biochem has 6 current directors:
- Pramod Kumar Kothari - Managing Director
- Kavita Devi Kothari - Whole-Time Director
- Siddhant Kothari - Whole-Time Director
- Piyush Kumar Goel - Director
- Hemendra Patsingh Dugar - Director
- Varun Kumar - Director
The GSTIN of Kothari Fermentation and Biochem is 07AABCK7907L1Z8, registered in Delhi. The company has 11 GST registrations in all, of which 10 are active and 1 is cancelled or inactive. Other active GSTINs include 07AABCK7907L2Z7 (Delhi), 03AABCK7907L1ZG (Punjab), 08AABCK7907L1Z6 (Rajasthan).
The CIN (Corporate Identification Number) of Kothari Fermentation and Biochem is L72411DL1990PLC042502. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Kothari Fermentation and Biochem is listed on BSE with code 507474.
Kothari Fermentation and Biochem has 30 court cases on record: 23 filed by the company and 6 filed against it. 12 are pending. Most are in the high courts.
Kothari Fermentation and Biochem was incorporated on 26 December 1990, making it 36+ years old. It is registered with the Registrar of Companies, Delhi.
Kothari Fermentation and Biochem has 14 deals on record (14 market trades); the latest was in March 2025.
The peers of Kothari Fermentation and Biochem by revenue are Krishna Enzytech Private Limited, Sanzyme Biologics Private Limited, Shri Tradco India Private Limited, Catalysts Bio-Technologies Private Limited, Meteoric Biopharmaceuticals Private Limited and 5 more, all in the Chemicals industry (Enzymes).
Rajiv Agarwal ceased to be Director on 13 Aug 2025. Varun Kumar was appointed as Director on 13 Aug 2025. Prasanna Kumar Pagaria ceased to be Director on 28 Aug 2023. Kothari Fermentation and Biochem has 27 board changes on record in total.
Kothari Fermentation and Biochem has 2 MSME Form 1 returns on record between 2023 and 2024, listing 16 overdue payments to 10 micro and small suppliers. The latest return was filed on 27 Apr 2024.